Efficacy and safety of trastuzumab emtansine versus trastuzumab deruxtecan in HER2-positive breast cancer with anti-HER2 therapy resistance: a multicenter retrospective study

R Rongbin Xu J Jie You X Xinqian Zhang Y Yuping Zheng Q Qi Qiu (Institute of Genetics and Developmental Biology, Chinese Academy of Sciences) X Xiexi Fang L Li Liu

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 30, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

R

Rongbin Xu

J

Jie You

X

Xinqian Zhang

Y

Yuping Zheng

Q

Qi Qiu

Institute of Genetics and Developmental Biology, Chinese Academy of Sciences

X

Xiexi Fang

L

Li Liu